David Araujo-Vilar
Overview
Explore the profile of David Araujo-Vilar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
69
Citations
808
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Brown R, Akinci B, Yosef M, Phillips H, Khalatbari S, Sorkina E, et al.
J Clin Endocrinol Metab
. 2025 Feb;
PMID: 39970125
Context: Lipodystrophy syndromes are rare disorders characterized by deficient adipose tissue, leading to insulin resistance, dyslipidemia, and organ system abnormalities. Objective: Our goal was to develop a lipodystrophy severity score...
2.
Diaz-Lopez E, Sanchez-Iglesias S, Castro A, Cobelo-Gomez S, Prado-Morana T, Araujo-Vilar D, et al.
Int J Mol Sci
. 2024 Sep;
25(17).
PMID: 39273270
Lipodystrophic laminopathies are a group of ultra-rare disorders characterised by the presence of pathogenic variants in the same gene () and other related genes, along with an impaired adipose tissue...
3.
Fernandez-Pombo A, Yildirim Simsir I, Sanchez-Iglesias S, Ozen S, Castro A, Atik T, et al.
Diabetes Obes Metab
. 2024 Aug;
26(11):4875-4886.
PMID: 39171574
Aim: To assess the disease burden of familial partial lipodystrophy (FPLD) caused by LMNA (FPLD2) and PPARG (FPLD3) variants to augment the knowledge of these rare disorders characterized by selective...
4.
Patni N, Chard C, Araujo-Vilar D, Phillips H, Magee D, Akinci B
Orphanet J Rare Dis
. 2024 Jul;
19(1):263.
PMID: 38992753
Background: Lipodystrophy syndromes are a heterogeneous group of rare, life-limiting diseases characterized by a selective loss of adipose tissue and severe metabolic complications. There is a paucity of information describing...
5.
Akinci B, von Schnurbein J, Araujo-Vilar D, Wabitsch M, Oral E
Diabetes
. 2024 Jun;
73(7):1039-1042.
PMID: 38900954
No abstract available.
6.
Ceccarini G, Akinci B, Araujo-Vilar D, Beghini M, Brown R, Carrion Tudela J, et al.
Ann Endocrinol (Paris)
. 2024 Mar;
85(4):308-316.
PMID: 38452868
Lipodystrophy syndromes are rare diseases primarily affecting the development or maintenance of the adipose tissue but are also distressing indirectly multiple organs and tissues, often leading to reduced life expectancy...
7.
Cobelo-Gomez S, Sanchez-Iglesias S, Fernandez-Pombo A, Araujo-Vilar D
Int J Mol Sci
. 2024 Jan;
25(2).
PMID: 38279282
The accumulation of farnesylated prelamin A has been suggested as one of the mechanisms responsible for the loss of fat in type 2 familial partial lipodystrophy due to variants in...
8.
Fernandez-Pombo A, Prado-Morana T, Diaz-Lopez E, Sanchez-Iglesias S, Castro A, Cobelo-Gomez S, et al.
J Clin Med
. 2023 Dec;
12(23).
PMID: 38068396
Acquired generalised lipodystrophy (AGL) is a rare disorder characterised by the gradual loss of fat that tends to generalise over time, the origin of which is still not fully clarified....
9.
Magno S, Ceccarini G, Corvillo F, Pelosini C, Gilio D, Paoli M, et al.
J Clin Endocrinol Metab
. 2023 Dec;
109(3):e932-e944.
PMID: 38061004
Background: Barraquer-Simons syndrome (BSS) is a rare, acquired form of lipodystrophy characterized by progressive loss of upper body subcutaneous fat, which affects face, upper limbs, and trunk. The pathogenesis of...
10.
Fernandez-Pombo A, Sanchez-Iglesias S, Castro-Pais A, Ginzo-Villamayor M, Cobelo-Gomez S, Prado-Morana T, et al.
Front Endocrinol (Lausanne)
. 2023 Nov;
14:1250203.
PMID: 38034001
The rarity of lipodystrophies implies that they are not well-known, leading to delays in diagnosis/misdiagnosis. The aim of this study was to assess the natural course and comorbidities of generalised...